WO2000015102A1 - Correction d'attributs pour la detection et/ou la surveillance continue d'analytes - Google Patents

Correction d'attributs pour la detection et/ou la surveillance continue d'analytes Download PDF

Info

Publication number
WO2000015102A1
WO2000015102A1 PCT/US1999/020796 US9920796W WO0015102A1 WO 2000015102 A1 WO2000015102 A1 WO 2000015102A1 US 9920796 W US9920796 W US 9920796W WO 0015102 A1 WO0015102 A1 WO 0015102A1
Authority
WO
WIPO (PCT)
Prior art keywords
attribute
sensor
analyte
biological fluid
tissue
Prior art date
Application number
PCT/US1999/020796
Other languages
English (en)
Other versions
WO2000015102A9 (fr
Inventor
Michael R. Hatch
Jonathan A. Eppstein
Stuart Mcrae
Original Assignee
Spectrx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrx, Inc. filed Critical Spectrx, Inc.
Priority to JP2000569690A priority Critical patent/JP4531983B2/ja
Priority to EP99945635A priority patent/EP1112021A1/fr
Priority to US09/786,830 priority patent/US6918874B1/en
Priority to CA002343762A priority patent/CA2343762A1/fr
Publication of WO2000015102A1 publication Critical patent/WO2000015102A1/fr
Publication of WO2000015102A9 publication Critical patent/WO2000015102A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Abstract

L'invention concerne un système et un procédé de détection et de mesure d'un analyte présent dans un fluide biologique animal. Un dispositif (10) de collecte est conçu pour être positionné à la surface des tissus d'un animal en vue de la collecte de fluide biologique. Le dispositif (10) de collecte comprend un détecteur (50) d'analyte placé de manière à être au contact du fluide biologique collecté, lequel détecteur génère un signal de mesure représentatif de l'analyte. Un détecteur (40) d'attributs au moins permet de mesurer un attribut associé à l'opération de collecte de fluide biologique du dispositif (10) de collecte ou à l'analyse du fluide biologique, détecteur qui génère un signal de mesure représentatif de l'attribut. Il est possible de procéder à des ajustements des paramètres de fonctionnement du dispositif (10) de collecte sur la base d'un ou de plusieurs attributs.
PCT/US1999/020796 1998-09-10 1999-09-10 Correction d'attributs pour la detection et/ou la surveillance continue d'analytes WO2000015102A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000569690A JP4531983B2 (ja) 1998-09-10 1999-09-10 検体の検出および／または連続的監視用の属性の補償
EP99945635A EP1112021A1 (fr) 1998-09-10 1999-09-10 Correction d'attributs pour la detection et/ou la surveillance continue d'analytes
US09/786,830 US6918874B1 (en) 1998-09-10 1999-09-10 Attribute compensation for analyte detection and/or continuous monitoring
CA002343762A CA2343762A1 (fr) 1998-09-10 1999-09-10 Correction d'attributs pour la detection et/ou la surveillance continue d'analytes

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9973398P 1998-09-10 1998-09-10
US60/099,733 1998-09-10
US14028599P 1999-06-18 1999-06-18
US14028399P 1999-06-18 1999-06-18
US60/140,285 1999-06-18
US60/140,283 1999-06-18

Publications (2)

Publication Number Publication Date
WO2000015102A1 true WO2000015102A1 (fr) 2000-03-23
WO2000015102A9 WO2000015102A9 (fr) 2000-10-05

Family

ID=27378892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/020796 WO2000015102A1 (fr) 1998-09-10 1999-09-10 Correction d'attributs pour la detection et/ou la surveillance continue d'analytes

Country Status (4)

Country Link
EP (1) EP1112021A1 (fr)
JP (1) JP4531983B2 (fr)
CA (1) CA2343762A1 (fr)
WO (1) WO2000015102A1 (fr)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024065A1 (fr) * 2000-09-22 2002-03-28 Knobbe, Lim & Buckingham Methode et appareil d'estimation et de controle en temps reel de parametres physiologiques
JP2004500948A (ja) * 2000-06-27 2004-01-15 ローズデイル　メディカル　インコーポレイテッド 被検成分モニター
JP2004522460A (ja) * 2000-06-01 2004-07-29 サイエンス　アプリケーションズ　インターナショナル　コーポレイション 健康状態をモニタリングするため、および経皮にて薬剤を送達するためのシステムおよび方法
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US6918874B1 (en) 1998-09-10 2005-07-19 Spectrx, Inc. Attribute compensation for analyte detection and/or continuous monitoring
US7141034B2 (en) 2000-06-08 2006-11-28 Altea Therapeutics Corporation Transdermal drug delivery device, method of making same and method of using same
JP2006527013A (ja) * 2003-06-06 2006-11-30 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 検査されるべき試料の一回的採取と分析のための統合テストユニット
WO2008091878A1 (fr) 2007-01-22 2008-07-31 Altea Therapeutics Corporation Système de formation de pores et de timbre transdermique et procédé d'utilisation correspondant
US7611723B2 (en) 2002-03-26 2009-11-03 Nanocyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US7632522B2 (en) 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
EP2168497A2 (fr) 1999-06-08 2010-03-31 Altea Therapeutics Corporation Appareil de micropores de membranes biologiques utilisant des dispositifs d'interface tissulaire à couche mince
US8062660B2 (en) 2000-09-28 2011-11-22 Nanocyte Inc. Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US8281675B2 (en) 2007-10-17 2012-10-09 Syneron Medical Ltd Dissolution rate verification
US8337493B2 (en) 2002-04-19 2012-12-25 Syneron Medical Ltd Handheld transdermal drug delivery and analyte extraction
US8834862B2 (en) 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
US9011419B2 (en) 2007-12-05 2015-04-21 Syneron Medical Ltd Disposable electromagnetic energy applicator
US9037229B2 (en) 2007-10-09 2015-05-19 Syneron Medical Ltd Magnetic patch coupling
US9504826B2 (en) 2009-02-18 2016-11-29 Syneron Medical Ltd Skin treatment apparatus for personal use and method for using same
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
US10004434B1 (en) 2013-03-15 2018-06-26 Georgetown University Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode
US11219390B2 (en) 2015-08-03 2022-01-11 Georgetown University Apparatus and method for delivery of antimicrobial during a transdermal sampling and delivery process

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US8016811B2 (en) 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US7766846B2 (en) * 2008-01-28 2010-08-03 Roche Diagnostics Operations, Inc. Rapid blood expression and sampling
KR101789687B1 (ko) * 2015-06-12 2017-10-25 서울대학교산학협력단 글루코오스 조절 시스템, 상기 글루코오스 조절 시스템의 형성 방법, 및 상기 글루코오스 조절 시스템을 이용한 글루코오스 조절 방법

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000998A1 (fr) * 1989-07-07 1991-01-24 Disetronic Holding Ag Appareil de mesure du glucose
WO1994006019A1 (fr) * 1992-08-28 1994-03-17 Via Medical Corporation Solutions d'etalonnage utilisees dans les analyses de fluides biologiques et leur procede d'utilisation
WO1994014062A1 (fr) * 1992-12-11 1994-06-23 Sudor Partners Procede et appareil permettant de determiner les especes chimiques presentes dans la transpiration
WO1996000110A1 (fr) * 1994-06-24 1996-01-04 Cygnus, Inc. Dispositif et procede pour le prelevement d'echantillons par iontophorese
WO1998000193A1 (fr) 1996-07-03 1998-01-08 Altea Technologies, Inc. Microporation mecanique multiple de la peau ou de la muqueuse
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
WO1999044507A1 (fr) 1998-03-06 1999-09-10 Spectrx, Inc. Dispositif integre de formation de pores, de prelevement de liquide biologique et d'analyse et procede associe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61115538A (ja) * 1984-11-10 1986-06-03 株式会社日立製作所 経皮センサ
JPH0428343A (ja) * 1990-04-27 1992-01-30 Nippondenso Co Ltd 汗中物質の測定装置

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000998A1 (fr) * 1989-07-07 1991-01-24 Disetronic Holding Ag Appareil de mesure du glucose
WO1994006019A1 (fr) * 1992-08-28 1994-03-17 Via Medical Corporation Solutions d'etalonnage utilisees dans les analyses de fluides biologiques et leur procede d'utilisation
WO1994014062A1 (fr) * 1992-12-11 1994-06-23 Sudor Partners Procede et appareil permettant de determiner les especes chimiques presentes dans la transpiration
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
WO1996000110A1 (fr) * 1994-06-24 1996-01-04 Cygnus, Inc. Dispositif et procede pour le prelevement d'echantillons par iontophorese
WO1998000193A1 (fr) 1996-07-03 1998-01-08 Altea Technologies, Inc. Microporation mecanique multiple de la peau ou de la muqueuse
WO1999044507A1 (fr) 1998-03-06 1999-09-10 Spectrx, Inc. Dispositif integre de formation de pores, de prelevement de liquide biologique et d'analyse et procede associe
WO1999044508A1 (fr) 1998-03-06 1999-09-10 Spectrx, Inc. Dispositif integre de formation de micropores, de prelevement et d'analyse et procede associe

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6918874B1 (en) 1998-09-10 2005-07-19 Spectrx, Inc. Attribute compensation for analyte detection and/or continuous monitoring
EP2168497A2 (fr) 1999-06-08 2010-03-31 Altea Therapeutics Corporation Appareil de micropores de membranes biologiques utilisant des dispositifs d'interface tissulaire à couche mince
EP2286868A2 (fr) 1999-06-08 2011-02-23 Altea Therapeutics Corporation Appareil pour créer des micropores dans des membranes biologiques à l'aide d'interface de tissus minces, et procédé de fabrication
US9332937B2 (en) 2000-06-01 2016-05-10 Georgetown University Systems and methods for monitoring health and delivering drugs transdermally
JP2004522460A (ja) * 2000-06-01 2004-07-29 サイエンス　アプリケーションズ　インターナショナル　コーポレイション 健康状態をモニタリングするため、および経皮にて薬剤を送達するためのシステムおよび方法
US8568315B2 (en) 2000-06-01 2013-10-29 Georgetown University Systems and methods for monitoring health and delivering drugs transdermally
JP2013166032A (ja) * 2000-06-01 2013-08-29 Science Applications Internatl Corp 健康状態をモニタリングするため、および経皮にて薬剤を送達するためのシステムおよび方法
JP2013056209A (ja) * 2000-06-01 2013-03-28 Science Applications Internatl Corp 健康状態をモニタリングするため、および経皮にて薬剤を送達するためのシステムおよび方法
JP2011200702A (ja) * 2000-06-01 2011-10-13 Science Applications Internatl Corp 健康状態をモニタリングするため、および経皮にて薬剤を送達するためのシステムおよび方法
US7931592B2 (en) 2000-06-01 2011-04-26 Georgetown University Systems and methods for monitoring health and delivering drugs transdermally
US7141034B2 (en) 2000-06-08 2006-11-28 Altea Therapeutics Corporation Transdermal drug delivery device, method of making same and method of using same
JP2004500948A (ja) * 2000-06-27 2004-01-15 ローズデイル　メディカル　インコーポレイテッド 被検成分モニター
JP4728557B2 (ja) * 2000-06-27 2011-07-20 インチュイティ メディカル インコーポレイテッド 被検成分モニター
WO2002024065A1 (fr) * 2000-09-22 2002-03-28 Knobbe, Lim & Buckingham Methode et appareil d'estimation et de controle en temps reel de parametres physiologiques
US8062660B2 (en) 2000-09-28 2011-11-22 Nanocyte Inc. Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US7998509B2 (en) 2000-09-28 2011-08-16 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US7632522B2 (en) 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US8486441B2 (en) 2000-09-28 2013-07-16 Nanocyte Inc. Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US8287912B2 (en) 2000-09-28 2012-10-16 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US7392080B2 (en) 2002-03-11 2008-06-24 Altea Therapeutics Corporation Transdermal drug delivery patch system, method of making same and method of using same
EP2319578A1 (fr) 2002-03-11 2011-05-11 Altea Therapeutics Corporation Système de timbre d'administration transdermique de médicaments, son procédé de fabrication et d'utilisation
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
EP3061492A1 (fr) 2002-03-11 2016-08-31 Nitto Denko Corporation Système de timbre d'administration transdermique de médicaments, son procédé de fabrication et d'utilisation
US8337868B2 (en) 2002-03-26 2012-12-25 Nanocyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US7611723B2 (en) 2002-03-26 2009-11-03 Nanocyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US8337493B2 (en) 2002-04-19 2012-12-25 Syneron Medical Ltd Handheld transdermal drug delivery and analyte extraction
JP2006527013A (ja) * 2003-06-06 2006-11-30 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 検査されるべき試料の一回的採取と分析のための統合テストユニット
US8834862B2 (en) 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
EP2674188A2 (fr) 2007-01-22 2013-12-18 Altea Therapeutics Corporation Système transdermique de délivrance de perméants
EP3210646A1 (fr) 2007-01-22 2017-08-30 Nitto Denko Corporation Système d'administration transdermique de perméants
WO2008091878A1 (fr) 2007-01-22 2008-07-31 Altea Therapeutics Corporation Système de formation de pores et de timbre transdermique et procédé d'utilisation correspondant
US9037229B2 (en) 2007-10-09 2015-05-19 Syneron Medical Ltd Magnetic patch coupling
US8281675B2 (en) 2007-10-17 2012-10-09 Syneron Medical Ltd Dissolution rate verification
US9011419B2 (en) 2007-12-05 2015-04-21 Syneron Medical Ltd Disposable electromagnetic energy applicator
US9504826B2 (en) 2009-02-18 2016-11-29 Syneron Medical Ltd Skin treatment apparatus for personal use and method for using same
US10004434B1 (en) 2013-03-15 2018-06-26 Georgetown University Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode
US11219390B2 (en) 2015-08-03 2022-01-11 Georgetown University Apparatus and method for delivery of antimicrobial during a transdermal sampling and delivery process

Also Published As

Publication number Publication date
WO2000015102A9 (fr) 2000-10-05
CA2343762A1 (fr) 2000-03-23
EP1112021A1 (fr) 2001-07-04
JP2003521953A (ja) 2003-07-22
JP4531983B2 (ja) 2010-08-25

Similar Documents

Publication Publication Date Title
US6918874B1 (en) Attribute compensation for analyte detection and/or continuous monitoring
EP1112021A1 (fr) Correction d'attributs pour la detection et/ou la surveillance continue d'analytes
US11571147B2 (en) Temperature-compensated analyte monitoring devices, systems, and methods thereof
US7041057B1 (en) Tissue interface device
US6549796B2 (en) Monitoring analyte concentration using minimally invasive devices
EP3733065B1 (fr) Procédé et système pour calibrer des dispositifs capteurs orthogonalement redondants
EP0702787B1 (fr) Appareil de captage biologique a procede et systeme d'evaluation de la temperature ambiante
EP2454595B1 (fr) Capteur in vivo compensé en température
US20080312859A1 (en) Method of Calibrating a System for Measuring the Concentration of Substances in Body and an Apparatus for Exercising the Method
US20080125751A1 (en) Temperature compensation for enzyme electrodes
US20230320631A1 (en) Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing
WO2008029110A2 (fr) Dispositif
AU3510701A (en) Attribute compensation for analyte detection and/or continuou s monitoring
WO2008076574A2 (fr) Compensation de température pour des électrodes à enzyme
CN112716490B (zh) 一种基于加权线性回归的连续血糖校准方法及装置
US20230218204A1 (en) Personalized calibration for glucose sensing
EP1553868A1 (fr) Appareil permettant de surveiller un patient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/5-5/5, DRAWINGS, REPLACED BY NEW PAGES 1/5-5/5; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: PA/A/2001/002601

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2343762

Country of ref document: CA

Ref document number: 2343762

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2000 569690

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1999945635

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09786830

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999945635

Country of ref document: EP

CFP Corrected version of a pamphlet front page

Free format text: REVISED ABSTRACT RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION

WWW Wipo information: withdrawn in national office

Ref document number: 1999945635

Country of ref document: EP